LivaNova PLC

Healthcare · Medical Devices

75.40$ -2.2% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

LivaNova PLC (LIVN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 2,641 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet LIVN
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	2,497	2,343	2,371	2,534	2,603	2,504	2,705	2,597	2,611	2,550	2,600	2,622	2,510	2,412	2,454	2,503	2,522	2,400	2,369	2,397	2,203	2,201	2,417	2,336	2,213	2,295	2,295	2,342	2,329	2,430	2,460	2,453	2,522	2,506	2,559	2,507	2,558	2,606	2,516	2,641
Current Assets	647	620	661	671	722	870	848	555	573	533	541	568	547	549	617	672	673	708	691	809	646	679	810	772	851	886	903	942	954	988	1,040	1,047	1,093	1,127	1,171	1,066	1,097	1,102	1,014	1,025
Cash	64	40	63	43	65	94	65	47	80	47	51	45	75	61	126	233	228	253	253	329	182	208	442	407	506	214	523	534	234	267	309	329	346	429	738	594	646	636	540	517
Cash & Short-Term Investments	64	40	63	43	65	94	65	47	80	47	51	45	75	61	126	233	228	253	253	329	182	208	442	407	506	214	523	534	234	267	309	329	346	429	738	594	646	636	540	517
Receivables	284	276	272	305	318	282	280	262	252	256	247	256	243	258	226	187	193	185	182	185	200	223	182	177	172	215	178	186	190	235	232	223	197	224	231	253	239	216	229	274
Inventory	198	184	192	205	215	145	154	158	153	154	161	169	168	164	170	177	178	115	125	127	124	106	115	119	122	129	142	156	162	148	153	155	162	148	154	165	168	165	166	173
Property, Plant & Equipment	245	224	205	211	214	192	192	186	188	191	243	242	234	236	236	237	191	164	158	207	153	191	148	143	139	183	149	150	181	–	–	–	–	–	–	–	–	–	–	–
Goodwill	731	692	698	764	781	784	876	966	969	957	952	962	946	916	889	902	918	922	910	918	905	900	897	898	742	769	774	779	767	783	772	766	782	750	762	793	791	793	786	779
Intangible Assets	650	609	606	713	718	535	692	798	784	770	759	721	699	608	587	583	584	438	424	419	409	400	390	389	365	369	364	357	348	261	254	248	249	237	237	239	235	230	225	217
Total Liabilities	680	636	636	690	689	689	886	814	826	1,046	1,113	1,138	1,015	1,028	1,062	1,169	1,171	1,291	1,303	1,356	891	906	1,125	1,054	1,066	1,087	1,068	1,101	1,104	1,152	1,238	1,211	1,212	1,186	1,524	1,384	1,400	1,406	1,305	1,316
Current Liabilities	317	317	324	342	356	406	460	368	347	497	622	596	469	513	530	268	282	309	295	702	658	697	308	264	288	297	316	288	295	335	328	303	324	392	742	827	828	808	763	707
Short-Term Debt	54	48	45	56	52	84	120	111	49	29	51	49	80	89	235	19	26	25	23	244	239	241	16	16	31	33	32	29	28	26	28	29	31	87	88	92	94	32	2.6	12
Accounts Payable	105	93	102	105	103	86	90	87	89	77	80	89	76	86	91	69	72	74	62	61	60	68	74	74	70	74	76	78	63	81	76	81	78	70	88	87	88	97	99	103
Long-Term Debt	91	75	76	70	72	62	64	50	108	140	142	174	273	260	316	639	637	642	646	431	11	9.8	456	460	518	518	520	568	568	569	605	605	604	550	549	348	349	345	285	290
Shareholders' Equity	1,817	1,707	1,735	1,844	1,914	1,815	1,819	1,783	1,785	1,504	1,487	1,483	1,495	1,384	1,393	1,333	1,351	1,109	1,066	1,040	1,312	1,295	1,292	1,282	1,147	1,208	1,227	1,241	1,225	1,278	1,222	1,243	1,310	1,320	1,034	1,123	1,157	1,200	1,211	1,325
Retained Earnings	15	-15	-3.3	44	72	-40	-49	-34	-41	-252	-266	-296	-264	-407	-370	-458	-473	-762	-782	-837	-880	-898	-895	-878	-986	-984	-977	-976	-983	-966	-1,008	-992	-959	-903	-1,231	-1,203	-1,177	-1,146	-1,123	-1,015
Shares Outstanding	49	49	48	48	49	48	49	49	49	49	48	48	49	48	49	49	49	49	49	49	52	53	54	54	54	54	54	54	54	54	54	55	55	55	54	55	55	55	56	56

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings